Anaplastic Oligodendroglioma (AO) Active Not Recruiting Phase 1 Trials for Lapatinib (DB01259)

Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant

IndicationStatusPhase
DBCOND0052374 (Anaplastic Oligodendroglioma (AO))Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02101905
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaTreatment